CYDY
CytoDyn Inc

7,083
Mkt Cap
$327.16M
Volume
0.00
52W High
$0.4945
52W Low
$0.1031
PE Ratio
-14.27
CYDY Fundamentals
50D MA
$0.2848
Beta
0.49
Avg. Volume
2.28M
EPS (Annual)
$0.0018
P/B
-3.28
Rev/Employee
$0.00
Loading...
Loading...
CytoDyn, Inc. is a clinical-stage biotechnology company, which focuses on the clinical development of innovative treatments for multiple therapeutic indications based on its product candidate, leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5. Its pipeline includes Leronlimab Clinical Development Pipeline and Long-Acting CCR5 Inhibitor Development Pipeline. The company was founded by Allen D. Allen on May 2, 2002 and is headquartered in Vancouver, WA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
13

Frequently Asked Questions

What is Market Cap of Cytodyn Inc?
What is the 52-week high for Cytodyn Inc?
What is the 52-week low for Cytodyn Inc?
What is the PE ratio of Cytodyn Inc?
What is the Price-to-Book ratio of Cytodyn Inc?
What is the 50-day moving average of Cytodyn Inc?
How many employess does Cytodyn Inc has?

Latest CYDY News

View
No CYDY news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.